Cardinal Health

4Q Revenues: $22 billion (+12%)

4Q Earnings: $321 million (+25%)

FY Revenues: $81 billion (+10%)

FY Earnings: $1 billion (-5%)

Comments: Revenue growth was led by Pharmaceutical Distribution and Provider Services segment, up 16% to $18 billion for the quarter and up 11% to $67 billion for the year. Operating earnings were down 11% to $268 million for the quarter and were even with the prior year at $1 billion. For the quarter, revenue for the Pharmaceutical Technologies and Services segment increased 5% to $747 million and operating earnings increased 28% to $96 million. For the year, revenue increased 4% to $2.8 billion, but operating earnings declined 3% to $305 million. For the quarter, Clinical Technologies and Services grew 9% to $649 million and for the year, revenue increased 11% to $2.4 billion.